camptothecin has been researched along with Cancer of Nasopharynx in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SB; Gu, LQ; Huang, SL; Huang, ZH; Huang, ZS; Li, D; Ou, JB; Ou, TM; Shen, LL; Tan, JH; Wu, WB | 1 |
| Garcia-Bournissen, F; Ito, S; Kim, R; Nathan, PC; Sakaguchi, S; Schwarz, UI | 1 |
| Cai, K; Chen, Y; Zhang, Y; Zhou, K | 1 |
| Chen, LM; Ding, Y; Fu, LW; Liang, YJ; Pan, QC; Xiong, HY; Yang, XP | 1 |
| Cheung, YB; Chowbay, B; Leong, SS; Poon, D; Tan, EH | 1 |
| Cheung, YB; Chowbay, B; Lee, A; Lee, EJ; Poon, D; Sparreboom, A; Tan, EH; Zhou, Q | 1 |
| Hu, JH; Huang, H; Kong, XT; Pan, XH; Sun, XY; Wu, W; Yu, L; Zhou, JH; Zhou, SM | 1 |
| Ling, G; Zhang, Q; Zhou, K | 1 |
| Huang, H; Pan, X; Zhou, J | 1 |
| Chang, JY; Chen, LT; Juang, SH; Liu, JF; Liu, TW | 1 |
| Adamson, RH; Mead, JA; Sieber, SM | 1 |
1 review(s) available for camptothecin and Cancer of Nasopharynx
| Article | Year |
|---|---|
Pharmacology of antitumor agents from higher plants.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aporphines; Camptothecin; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Etoposide; Humans; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Maytansine; Melanoma; Naphthoquinones; Nasopharyngeal Neoplasms; Neoplasms; Neoplasms, Experimental; Phenanthrenes; Structure-Activity Relationship; Teniposide; Vinblastine; Vincristine | 1976 |
1 trial(s) available for camptothecin and Cancer of Nasopharynx
| Article | Year |
|---|---|
Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma; Diarrhea; Disease Progression; Drug Administration Schedule; Female; Humans; Irinotecan; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Quality of Life; Salvage Therapy; Survival Analysis; Treatment Outcome | 2005 |
9 other study(ies) available for camptothecin and Cancer of Nasopharynx
| Article | Year |
|---|---|
Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Survival; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Etoposide; Humans; Inhibitory Concentration 50; Lung Neoplasms; Naphthoquinones; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Plasmids; Pyrans; Quinones; Sesquiterpenes; Structure-Activity Relationship; Telomerase; Topoisomerase Inhibitors | 2011 |
Prolonged neutropenia after irinotecan-based chemotherapy in a child with polymorphisms of UGT1A1 and SLCO1B1.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Child; Female; Genetic Predisposition to Disease; Glucuronosyltransferase; Humans; Irinotecan; Liver-Specific Organic Anion Transporter 1; Nasopharyngeal Neoplasms; Neutropenia; Organic Anion Transporters; Polymorphism, Single Nucleotide; Rhabdomyosarcoma, Alveolar | 2009 |
[Mitochondrial mechanisms of CPT-induced apoptosis in nasopharyngeal carcinoma cells].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Humans; Membrane Potentials; Mitochondria; Nasopharyngeal Neoplasms; Tumor Cells, Cultured | 2001 |
[Experimental studies on treatment of nasopharyngeal carcinoma with combination regimen of hydroxycamptothecin and etoposide].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Etoposide; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Asian People; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Female; Genes, MDR; Genotype; Heterozygote; Homozygote; Humans; Irinotecan; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Nasopharyngeal Neoplasms; Neoplasm Proteins; Phenotype; Polymorphism, Single Nucleotide | 2005 |
Epstein-Barr virus BHRF1 prohibits the cells of nasopharyngeal carcinoma from apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Division; Gene Expression; Gene Transfer Techniques; Genes, Viral; Genetic Vectors; Herpesvirus 4, Human; Humans; Immediate-Early Proteins; Immunity, Innate; Nasopharyngeal Neoplasms; Tumor Cells, Cultured | 1997 |
[Apoptosis of nasopharyngeal carcinoma cells induced by topoisomerase I inhibitor].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Humans; Nasopharyngeal Neoplasms; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1997 |
[The effect of EB virus bhrfl gene expressing on the topoisomerase I expression in nasopharyngeal carcinoma cell line].
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; DNA Topoisomerases, Type I; Gene Expression; Genes, Viral; Herpesvirus 4, Human; Humans; Nasopharyngeal Neoplasms; Tumor Cells, Cultured; Viral Proteins | 2001 |
Novel mutation of topoisomerase I in rendering cells resistant to camptothecin.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Carboplatin; Carmustine; Catalysis; Cell Division; Cisplatin; DNA Damage; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gene Expression; Humans; Nasopharyngeal Neoplasms; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tumor Cells, Cultured | 2002 |